Ikarian Capital, LLC Codiak Bio Sciences, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.24 - $6.96 $116,876 - $363,151	-52,177 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.3 - $12.95 $10,737 - $32,336	2,497 Added 5.03%	52,177 $328,000
Q4 2021 Feb 14, 2022	SELL	$10.0 - $16.78 $702,150 - $1.18 Million	-70,215 Reduced 58.56%	49,680 $554,000
Q3 2021 Nov 15, 2021	BUY	$15.58 - $22.88 $1.87 Million - $2.74 Million	119,895 New	119,895 $1.96 Million

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.